The etiologic abnormality and cornerstone for diagnosis of CML is the “Philadelphia chromosome”—a balanced translocation between chromosomes 9 and 22 leading to fusion of the BCR and ABL1 genes and BCR-ABL1 fusion protein [43]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.